Severe inflammation in C57/BL6 mice leads to prolonged cognitive impairment by initiating the IL-1β /TRPM2 pathway

Yujiao Yang,Zhihua Yao,Hushan Wang,Shuaiying Jia,Mingfei Wang,Shan Wang,Debo Yun

DOI: https://doi.org/10.1016/j.intimp.2023.111380

IF: 5.714

2024-01-04

International Immunopharmacology

Abstract:Background Sepsis could lead to chronic cognitive impairment by unclear molecular mechanisms. Transient receptor potential melastatin-2 (TRPM2) is essential against immunity-related activities and inflammation. Our study attempted to decipher the relationship between cognitive impairment caused by severe inflammation and TRPM2 expression levels. Methods Severe inflammation was induced by intraperitoneally injecting C57/BL6 mice with a high dosage (5 mg kg −1 ) of Lipopolysaccharide (LPS). Fear conditioning and a Morris water maze test were performed to examine the cognitive abilities of the mice. Moreover, the signaling and expression of pro-inflammatory cytokines and TRPM2 were measured using Western blotting and Reverse transcription-polymerase chain reaction (RT-PCR). Flow cytometry and immunofluorescence staining helped to determine the astrocyte apoptosis rate. Results Severe inflammation can lead to long-term cognitive impairment in C57/BL6 mice. The interleukin-1 beta (IL-1β) levels intra-hippocampus were significantly elevated until P14 post-LPS introduction. At both P7 and P14, there is an up-regulation of TRPM2 expression within hippocampus. Administration of recombinant IL-1β to astrocytes results in a significant up-regulation of TRPM2 expression. IL-1β or TRPM2 level knockdown helped counter the cognitive impairment caused by significant inflammation. Conclusions A continuous increase in IL-1β levels within the hippocampus can lead to cognitive impairment by enhancing TRPM2 levels caused by severe inflammation.

pharmacology & pharmacy,immunology